Market expert Sandip Sabharwal maintains a constructive long-term outlook but stresses selectivity due to near-term risks like rising input costs and competition. He favors midcaps and selective smallcaps, seeing opportunities in consumer durables, while cautioning on financials and quick commerce. Large pharma deals require careful integration and valuation assessment.
Sebi approves 3 IPOs of Cosmic PV, Monomark, RKB Global along with NSE
SEBI has approved IPOs for Cosmic PV Power, Monomark Engineering, and RKB Global, alongside the National Stock Exchange’s major public offer. These approvals highlight a
September 4, 2026